4.8 Review

Viral epigenomes in human tumorigenesis

期刊

ONCOGENE
卷 29, 期 10, 页码 1405-1420

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2009.517

关键词

epigenetics; DNA methylation; histone modification; virus; viral oncogenes; human cancer

资金

  1. Spanish Association Against Cancer (AECC)
  2. Fundacion Mutua Madrilena
  3. Swiss Bridge Award
  4. [MCYT08-03]
  5. ICREA Funding Source: Custom

向作者/读者索取更多资源

Viruses are associated with 15-20% of human cancers worldwide. In the last century, many studies were directed towards elucidating the molecular mechanisms and genetic alterations by which viruses cause cancer. The importance of epigenetics in the regulation of gene expression has prompted the investigation of virus and host interactions not only at the genetic level but also at the epigenetic level. In this study, we summarize the published epigenetic information relating to the genomes of viruses directly or indirectly associated with the establishment of tumorigenic processes. We also review aspects such as viral replication and latency associated with epigenetic changes and summarize what is known about epigenetic alterations in host genomes and the implications of these for the tumoral process. The advances made in characterizing epigenetic features in cancer-causing viruses have improved our understanding of their functional mechanisms. Knowledge of the epigenetic changes that occur in the genome of these viruses should provide us with markers for following cancer progression, as well as new tools for cancer therapy. Oncogene (2010) 29, 1405-1420; doi:10.1038/onc.2009.517; published online 25 January 2010

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Cancer epigenetics in clinical practice

Veronica Davalos, Manel Esteller

Summary: Cancer development is caused by changes in the structure and function of the genome. Epigenetic alterations regulate gene expression programs that promote tumorigenesis and can be used as useful tools in clinical decision making. Unlike genetic changes, epigenetic modifications can be reversed, making them an attractive target for drug development.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Review Oncology

International consensus on the initial diagnostic workup of cancer of unknown primary

Iris van der Strate, Fatemeh Kazemzadeh, Iris D. Nagtegaal, Debbie Robbrecht, Agnes van de Wouw, Catarina S. Padilla, Saskia Duijts, Manel Esteller, F. Anthony Greco, Nicholas Pavlidis, Amir Qaseem, Petur Snaebjornsson, Sophie Veldhuijzen van Zanten, Caroline Loef

Summary: The study proposes a multi-layer classification for the diagnostic workup of CUP using the Delphi method. The recommended initial diagnostic includes history and physical examination, full blood count, serum marker analysis, biopsy of accessible lesion, CT scan, and immunohistochemical testing. Consensus was also reached on the need for an ideal diagnostic lead time for CUP patients.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2023)

Article Biochemistry & Molecular Biology

Global Impairment of Immediate-Early Genes Expression in Rett Syndrome Models and Patients Linked to Myelination Defects

Paolo Petazzi, Olga Caridad Jorge-Torres, Antonio Gomez, Iolanda Scognamiglio, Jordi Serra-Musach, Angelika Merkel, Daniela Grases, Clara Xiol, Mar O'Callaghan, Judith Armstrong, Manel Esteller, Sonia Guil

Summary: Rett syndrome is a severe neurodevelopmental disease caused by mutations in the MeCP2 gene, which affects synaptic plasticity and neuronal activity. The MeCP2 protein is critical for the proper expression of immediate-early genes (IEGs) involved in activity-dependent responses, and abnormal expression of IEGs is found in MeCP2-deficient neurons and in RTT patients. These findings highlight the importance of IEGs in synaptic development and the regulatory role of MeCP2.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

A trans-omics assessment of gene-gene interaction in early-stage NSCLC

Jiajin Chen, Yunjie Song, Yi Li, Yongyue Wei, Sipeng Shen, Yang Zhao, Dongfang You, Li Su, Maria Moksnes Bjaanaes, Anna Karlsson, Maria Planck, Johan Staaf, Aslaug Helland, Manel Esteller, Hongbing Shen, David C. C. Christiani, Ruyang Zhang, Feng Chen

Summary: This study identified significant gene-gene interactions associated with non-small-cell lung cancer survival through a three-step analytic strategy. Two interactions were found at both the epigenetic and transcriptional levels, providing potential clues for precision treatment of NSCLC.

MOLECULAR ONCOLOGY (2023)

Review Genetics & Heredity

Genetic and epigenetic defects of the RNA modification machinery in cancer

Ines Orsolic, Arnaud Carrier, Manel Esteller

Summary: Cancer was once believed to be solely genetic, but now it is known that dysregulated genetic and epigenetic mechanisms work together in cancer development. Recently, the epitranscriptome, which refers to chemical modifications of RNA molecules, has been found to play a role in regulating RNA function. Specific enzymes responsible for these modifications, known as RMPs, are being investigated for their potential as therapeutic targets or diagnostic markers in cancer. The study of epitranscriptomics has revealed the critical role of RNA modifications in cellular pathways and their potential importance in cancer treatment.

TRENDS IN GENETICS (2023)

Article Hematology

SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms

Antonio Lahera, Pilar Lopez-Nieva, Hernan Alarcon, Jose L. Marin-Rubio, Maria A. Cobos-Fernandez, Pablo Fernandez-Navarro, Agustin F. Fernandez, Laura Vela-Martin, Isabel Sastre, Sara Ruiz-Garcia, Pilar Llamas, Jose L. Lopez-Lorenzo, Javier Cornago, Javier Santos, Jose Fernandez-Piqueras, Maria Villa-Morales

Summary: Despite frequent alterations in the JAK/STAT pathway in T-ALL/LBL, there is currently no approved therapy for patients with constitutive JAK/STAT signaling. This study identifies SOCS3 hypermethylation as a recurrent event in T-ALL/LBL and demonstrates its potential as a therapeutic target by counteracting the constitutive activation of the JAK/STAT pathway through different molecular mechanisms.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Maternal obesity and gestational diabetes reprogram the methylome of offspring beyond birth by inducing epigenetic signatures in metabolic and developmental pathways

Juan Jose Alba-Linares, Raul F. Perez, Juan Ramon Tejedor, David Bastante-Rodriguez, Francisco Ponce, Nuria Garcia Carbonell, Rafael Gomez Zafra, Agustin F. Fernandez, Mario F. Fraga, Empar Lurbe

Summary: Maternal obesity or gestational diabetes mellitus are significant risk factors for cardiometabolic diseases in children. A study on the DNA methylation landscape of children born to mothers with obesity and gestational diabetes found abundant methylation changes during the first 6 months of life, associated with genes and pathways involved in fatty acid metabolism, developmental processes, and mitochondrial bioenergetics. The study also revealed an interaction between developmental methylation changes and maternal metabolic alterations.

CARDIOVASCULAR DIABETOLOGY (2023)

Article Biochemistry & Molecular Biology

Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome

Aleix Noguera-Castells, Carlos A. Garcia-Prieto, Damiana Alvarez-Errico, Manel Esteller

Summary: DNA methylation, a well-studied epigenetic mark, plays a critical role in gene regulation and is altered in cancer and other diseases. The newly developed 900K EPIC v2 microarray provides significant improvements in coverage and includes additional probes for DNA cis-regulatory regions. Validation studies demonstrate the reproducibility and versatility of this updated tool for studying the DNA methylome.

EPIGENETICS (2023)

Article Biochemistry & Molecular Biology

Unexpected thermodynamic signature for the interaction of hydroxymethylated DNA with MeCP2

David Ortega-Alarcon, Rafael Claveria-Gimeno, Sonia Vega, Olga C. Jorge-Torres, Manel Esteller, Olga Abian, Adrian Velazquez-Campoy

Summary: Hydroxymethylated cytosine (5hmC) is a stable DNA epigenetic mark that interacts with MeCP2 in a distinct mode with a specific thermodynamic signature. Mutations associated with Rett syndrome alter the interaction between MeCP2 and dsDNA in a cytosine modification-specific manner, which may be correlated with disease onset time and clinical severity score.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)

Article Biochemistry & Molecular Biology

Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease

Miriam Gene, Miriam Cuatrecasas, Irene Amat, Jesus Alberto Veiga, Maria Jesus Fernandez Acenero, Victoria Fuste Chimisana, Jordi Tarragona, Ismael Jurado, Rebeca Fernandez-Victoria, Carolina Martinez Ciarpaglini, Cristina Alenda Gonzalez, Carlos Zac, Pilar Ortega de la Obra, Maria Teresa Fernandez-Figueras, Manel Esteller, Eva Musulen

Summary: Colitis-associated colorectal carcinoma (CAC) in inflammatory bowel disease (IBD) is caused by p53 alterations and follows a chronic inflammation-dysplasia-cancer carcinogenesis pathway. Gastric metaplasia (GM) is described as the initial event of serrated colorectal cancer (CRC) in the colon mucosa under chronic stress. This study analyzed p53 alterations and microsatellite instability (MSI) to characterize CAC and investigate its relationship with GM. Results showed that p53 mutation pattern was present in more than half of the CAC cases, with stable (MSS) tumors being the most common and MUC5AC negative. Only six unstable (MSI-H) tumors had wild-type p53 pattern (p=0.010) and were MUC5AC positive (p=0.005). MUC5AC staining was more frequently observed in intestinal mucosa with inflammation or chronic changes than in CAC, particularly in those with wild-type p53 pattern and MSS.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Oncology

Global Shift in Alternative Splicing and Therapeutic Susceptibilities in Leukemia Driven by METTL3 Overexpression

Maxime Janin, Manel Esteller

Summary: Mutations in splicing factors are commonly found in CLL, but other mechanisms such as METTL3 overexpression can also lead to abnormal splicing. METTL3 deposits epitranscriptomic marks in spliceosome transcripts, causing aberrant splicing, but also vulnerability to METTL3 inhibitors.

BLOOD CANCER DISCOVERY (2023)

Review Oncology

Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics

Maxime Janin, Veronica Davalos, Manel Esteller

Summary: Most cancer-related deaths and illnesses can be attributed to metastasis. The role of epigenetic and epitranscriptomic changes in the origin and progression of cancer has been extensively demonstrated. These two-layer regulatory mechanisms, driven by DNA or RNA modifiers, are finely controlled in normal tissue but dysregulated in cancer. Understanding these mechanisms could have important clinical implications for prevention and management of advanced malignancies. Reversing these epi-alterations with small molecules or inhibitors against epi-modifiers could offer novel therapeutic alternatives.

CANCER AND METASTASIS REVIEWS (2023)

Letter Oncology

Response to Kang et al.

Carlos A. Garcia-Prieto, Veronica Davalos, Manel Esteller

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

Lucia Salz, Alexander Seitz, Daniel Schaefer, Julia Franzen, Tatjana Holzer, Carlos A. Garcia-Prieto, Iris Buerger, Olaf Hardt, Manel Esteller, Wolfgang Wagner

Summary: CAR T cell expansion during culture leads to DNA hypermethylation, which downregulates the expression of genes relevant to T cell function. This hypermethylation signature can predict cell culture time and is associated with reduced long-term survival and therapeutic outcome in CAR T cell products.

LEUKEMIA (2023)

Article Oncology

Multi-omic integration of DNA methylation and gene expression data reveals molecular vulnerabilities in glioblastoma

Pablo Santamarina-Ojeda, Juan Ramon Tejedor, Raul F. Perez, Virginia Lopez, Annalisa Roberti, Cristina Mangas, Agustin F. Fernandez, Mario F. F. Fraga

Summary: Glioblastoma (GBM) is an aggressive and heterogeneous type of cancer, posing challenges in developing effective treatments. Incorporating molecular features into diagnosis has improved categorization of GBM subtypes, revealing subtype-specific vulnerabilities. By integrating gene expression and DNA methylation data, potential vulnerabilities in GBM patients were identified, implicating the AP-1, SMAD3, and RUNX1/RUNX2 pathways in tumor development. Inhibition of these pathways, with or without the chemotherapy agent temozolomide, led to impaired tumor growth, particularly in the aggressive, mesenchymal-like subtype. These findings have implications for personalized therapeutic approaches.

MOLECULAR ONCOLOGY (2023)

暂无数据